Doença de Kawasaki incompleta: Apresentação como amigdalite aguda complicada
DOI:
https://doi.org/10.25753/BirthGrowthMJ.v31.i4.23745Palavras-chave:
abcesso retrofaríngeo, amigdalite aguda, doença de Kawasaki, infeção cervical profundaResumo
Introdução: A doença de Kawasaki (DK) é uma das vasculites pediátricas mais comuns, podendo ter complicações importantes, nomeadamente aneurisma coronário (AC). Pode apresentar-se apenas com febre e manifestações otorrinológicas, que podem ser erradamente interpretadas como infeções cervicais profundas.
Caso clínico: Uma criança do sexo feminino de quatro anos de idade foi internada por suspeita de amigdalite aguda complicada. A tomografia computorizada cervical sugeriu abcesso retrofaríngeo inicial. A criança foi tratada com antibióticos endovenosos e submetida a duas intervenções cirúrgicas, sem melhoria. Ao 10º dia de febre, o aparecimento de exantema generalizado e edema das mãos levantou suspeita de DK incompleta. O ecocardiograma revelou AC. A criança foi tratada com imunoglobulina endovenosa e corticoterapia, com melhoria clínica e laboratorial e regressão rápida e persistente do AC.
Discussão: O índice de suspeição de DK deve manter-se elevado perante casos de suspeita de amigdalite complicada sem resposta a tratamento adequado. O tratamento precoce é essencial para reduzir sequelas cardiovasculares. Dois ou três critérios com análises/ecocardiograma compatíveis confirmam o diagnóstico de DK incompleta.
Downloads
Referências
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004; 114(6): 1708-33.
Ramphul K, Mejias SG. Kawasaki disease: a comprehensive review. Arch Med Sci - Atheroscler Dis 2018; 3: e41-e45.
Kushner HI, Bastian JF, Turner CL, Burns JC. The two emergences of kawasaki syndrome and the implications for the developing world. Pediatr Infect Dis J 2008; 27(5): 377-83.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation 2017; 135(17):e927-e999.
Minich LLA, Sleeper LA, Atz AM, McCrindle BW, Lu M, Colan SD, et al. Delayed diagnosis of Kawasaki disease: What are the risk factors? Pediatrics 2007; 120(6): e1434-40.
Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 2007; 49(4): 421-6.
Harris JP, Weisman MH. Head and neck manifestations of systemic disease. Med Clin North Am 2007; 102(6): 1095-1107.
Rouault M, Coudert A, Hermann R, Gillet Y, Truy E, Ayari-Khalfallah S. Otorhinolaryngological manifestations and delayed diagnosis in Kawasaki disease. Int J Pediatr Otorhinolaryngol 2019; 121: 137-142.
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140(3): e20171904.
Kanegaye JT, Van Cott E, Tremoulet AH, Salgado A, Shimizu C, Kruk P, et al. Lymph-node-first presentation of kawasaki disease compared with bacterial cervical adenitis and typical kawasaki disease. J Pediatr 2013; 162(6):1259-63.
Nomura O, Hashimoto N, Ishiguro A, Miyasaka M, Nosaka S, Oana S, et al. Comparison of patients with Kawasaki disease with retropharyngeal edema and patients with retropharyngeal abscess. Eur J Pediatr 2014; 173(3): 381-6.
Sasaki T, Miyata R, Hatai Y, Makita K, Tsunoda K. Hounsfield unit values of retropharyngeal abscess-like lesions seen in Kawasaki disease. Acta Otolaryngol 2014; 134(4): 437-40.
Tona R, Shinohara S, Fujiwara K, Kikuchi M, Kanazawa Y, Kishimoto I, et al. Risk factors for retropharyngeal cellulitis in Kawasaki disease. Auris Nasus Larynx 2014; 41(5): 455-8.
Chen S, Dong Y, Yin Y, Krucoff MW. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: A meta-analysis. Vol. 99, Heart 2013; 99(2): 76-82.
Dhanrajani A, Yeung RSM. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease. Curr Opin Rheumatol 2017; 29(5):547-552.
Tirelli F, Marrani E, Giani T, Cimaz R. One year in review: Kawasaki disease. Curr Opin Rheumatol 2020; 32(1): 15-20.
European Centre for Disease Prevention and Control. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. ECDC 2020.
Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG, et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr Cardiol 2020; 41(7): 1391-1401.
Harwood R, Allin B, Jones CE, Whittaker E, Ramnarayan P, Ramanan A, et al. A national consensus management pathway for Paediatric Inflammatory Multisystem Syndrome - Temporally associated with SARS-CoV-2 (PIMS-TS): The results of a national Delphi process. Lancet Child Adolesc Health 2020; 5(2):133-141.
Downloads
Publicado
Como Citar
Edição
Secção
Licença
Direitos de Autor (c) 2022 Rita Pissarra
Este trabalho encontra-se publicado com a Creative Commons Atribuição-NãoComercial 4.0.
Copyright and access
This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public provides greater global democratization of knowledge.
The works are licensed under a Creative Commons Attribution Non-commercial 4.0 International license.
Nascer e Crescer – Birth and Growth Medical Journal do not charge any submission or processing fee to the articles submitted.
